MATCHRX

Lobbying Spend

—

Filings

Firms Hired

Active Period

2013–2016

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2016	—	2	1
2015	—	5	2
2014	—	4	1
2013	—	2	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
AKIN GUMP STRAUSS HAUER FELD	—	6
ABRAHAM & ROETZEL, LLC	—	7

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	10
SENATE	10
Food & Drug Administration (FDA)	5

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	7
Health Issues	Health Issues	6

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3204113th Congress

Drug Quality and Security Act

2013 · fourth_quarter · Firm: ABRAHAM & ROETZEL, LLC

Cited source text and reported amounts

HR. 3204 Drug Quality and Security Act.

Client expense: — · Firm income: $10,000

Matched citations: HR. 3204

H.R. 3204113th Congress

Drug Quality and Security Act

2013 · fourth_quarter · Firm: ABRAHAM & ROETZEL, LLC

Cited source text and reported amounts

HR 3204 Drug Quality and Security Act.

Client expense: — · Firm income: —

Matched citations: HR 3204

MATCHRX — Lobbying Disclosure | Poliscope